Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
Gene fusions involving the ERG transcription factor and point mutations in the ubiquitin ligase adaptor SPOP are two truncal mutations that are mutually exclusively present in prostate cancer. Here, the authors show that mutations in SPOP render prostate tumor cells sensitive to antiandrogen therapy...
Main Authors: | Tiziano Bernasocchi, Geniver El Tekle, Marco Bolis, Azzurra Mutti, Arianna Vallerga, Laura P. Brandt, Filippo Spriano, Tanya Svinkina, Marita Zoma, Valentina Ceserani, Anna Rinaldi, Hana Janouskova, Daniela Bossi, Manuela Cavalli, Simone Mosole, Roger Geiger, Ze Dong, Cai-Guang Yang, Domenico Albino, Andrea Rinaldi, Peter Schraml, Simon Linder, Giuseppina M. Carbone, Andrea Alimonti, Francesco Bertoni, Holger Moch, Steven A. Carr, Wilbert Zwart, Marianna Kruithof-de Julio, Mark A. Rubin, Namrata D. Udeshi, Jean-Philippe P. Theurillat |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-20820-x |
Similar Items
-
SPOP the mutation
by: Leah Rider, et al.
Published: (2015-10-01) -
The establishment of an immunosensor for the detection of SPOP
by: Song Yue, et al.
Published: (2021-06-01) -
SPOP mutation leads to genomic instability in prostate cancer
by: Gunther Boysen, et al.
Published: (2015-09-01) -
Promoter methylation and transcriptional regulation of the SPOP gene
by: Li Yi-Nong, et al.
Published: (2011) -
The emerging role of SPOP protein in tumorigenesis and cancer therapy
by: Yizuo Song, et al.
Published: (2020-01-01)